About the Product

Description


Dexidone 100 Injection containing Dexmedetomidine is used for sedation and supportive management in intensive care and procedural settings. It helps provide calm sedation while supporting patient comfort during critical care treatment.

Dexmedetomidine works as a selective alpha-2 adrenergic receptor agonist that helps produce sedative and anxiolytic effects while maintaining cooperative patient responsiveness.

The injection is widely used in intensive care units and hospital settings for monitored sedation management, leading to consistent institutional demand.

With increasing advancement in critical care infrastructure and rising ICU admissions, this product offers strong business potential for retailers and distributors. Its established sedative action, broad clinical relevance, and steady market demand make it a reliable product for growth in the critical care segment.

Some patients may experience low blood pressure, slow heart rate, dry mouth, nausea, or dizziness. Rarely, severe hypotension, cardiac rhythm disturbances, or allergic reactions may occur and require immediate medical attention.

Dexidone 100 Injection is indicated for sedation of mechanically ventilated patients in intensive care units, procedural sedation, and perioperative sedation under medical supervision. It helps maintain patient comfort, reduce anxiety, and facilitate medical procedures safely.

This injection should be administered strictly under the supervision of qualified healthcare professionals in a monitored clinical setting. Continuous monitoring of blood pressure, heart rate, and oxygen levels is recommended during administration.

Store below 25°C, protected from direct sunlight and freezing. Keep the vial in its original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Dexmedetomidine 100mcg Injection in the PCD pharma franchise market? What are the business opportunities for Dexmedetomidine 100mcg Injection in the PCD pharma franchise market?

Dexmedetomidine 100mcg Injection has strong demand in the anesthesia, ICU, and critical care segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include Dexmedetomidine Injection in their product range?

Medical distributors and wholesalers can benefit from consistent hospital demand in ICU sedation, surgical procedures, ventilated patients, and intensive care management under specialist supervision.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for Dexmedetomidine 100mcg Injection?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dexmedetomidine 100mcg Injection with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this ICU product?

Wholesalers and medical agencies benefit from steady hospital procurement, high-value institutional orders, and strong demand in critical care and anesthesia departments when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Dexmedetomidine 100mcg Injection?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this ICU formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.